Abstract:SESSION TITLE: Mechanisms of Lung Injury SESSION TYPE: Original Investigation Slide PRESENTED ON: Saturday, April 16, 2016 at 04:00 PM - 05:00 PM PURPOSE: Acute lung injury (ALI), the basis of acute respiratory distress syndrome (ARDS) is a critically clinic syndrome with high morbidity and mortality in intensive care units (ICU). Currently, there is no effective pharmacological treatment for acute lung injury. STAT3 signaling pathway plays a crucial role in the inflammation process of acute lung injury (ALI). This study aimed to investigate the protective effect of LLL12, an inhibitor of STAT3, and SOCS3, a negative regulator of STAT3, on LPS-induced ALI. METHODS: The protein content of pro-inflammatory cytokines and chemokines in bronchoalveolar lavage fluid, the histopathologic of the lung, the innate immunity cells in lung tissue in vivo, as well as the protein expressions of STAT3, STAT1, ERK1/2, and NF-κB in cultured macrophages in vitro were detected. RESULTS: The C57BL/6，SOCS3fl/fl and LysMCre-SOCS3fl/fl mice were randomly divided into 3 groups: control, LPS and LLL12 + LPS groups. The mice were sacrificed using arotic phlebotomy at 24, 48, 72 and 96 h after LPS deposition and injured lung specimens were harvested. LPS induces STAT3 activation and gene expression in cells isolated from the BALF in vivo. LLL12 pretreatment significantly ameliorated lung inflammatory responses in LPS-induced ALI. In addition, LLL12 suppresses STAT3 activation and pro-inflammatory cytokines expression in macrophages from SOCS3fl/fl and LysMCre-SOCS3fl/fl mice. SOCS3 negatively regulates LPS-induced STAT3 activation and production of inflammatory mediators in BAL fluids. However, the enhanced lung inflammation in LPS-induced lung injury in mice with myeloid deletion of SOCS3 could be inhibited by LLL12. CONCLUSIONS: Our experimental findings indicated that the specific inhibitor of STAT3, LLL12, can protect mice against LPS-induced ALI and that its underlying mechanism may be related to the inhibition of STAT3 signaling pathway activation. CLINICAL IMPLICATIONS: The identification of STAT3-regulated downstream mediators (including cytokines/chemokines) will lead to a better understanding how STAT3 regulates acute lung inflammatory responses. Elucidating the function of STAT3 may help identify new prospective targets for therapeutic intervention in lung diseases. DISCLOSURE: The following authors have nothing to disclose: Liang Dong No Product/Research Disclosure Information

Effect of SIS3 on Extracellular Matrix Remodeling and Repair in a Lipopolysaccharide-Induced ARDS Rat Model

Protective Role of Adipose-Derived Stem Cells in Staphylococcus aureus-Induced Lung Injury is Mediated by RegIIIγ Secretion.

An Essential Role for Stat3 in Regulating Igg Immune Complex-Induced Pulmonary Inflammation

Protective effect of suppressing STAT3 activity in LPS-induced acute lung injury

3,5,4′-Tri-o-acetylresveratrol Attenuates Lipopolysaccharide-Induced Acute Respiratory Distress Syndrome Via MAPK/SIRT1 Pathway

Glycogen Synthase Kinase-3Β Inhibitor Reduces LPS-induced Acute Lung Injury in Mice

Silencing information regulator 1 ameliorates lipopolysaccharide-induced acute lung injury in rats via the upregulation of caveolin-1

Targeting EB3-IP 3 R3 Interface with Cognate Peptide Protects from Acute Respiratory Distress Syndrome

S1PR3 inhibition protects against LPS-induced ARDS by inhibiting NF-κB and improving mitochondrial oxidative phosphorylation

Protective Effects and Mechanisms of Suppressing Stat3 Pathway on Lps-Induced Acute Lung Injury

Stellate Ganglion Block Attenuates LPS-Induced Acute Lung Injury by Activating Sirt3 Regulation of Oxidative Stress and Inflammation

PNSC5325 prevents acute respiratory distress syndrome by alleviating inflammation and inhibiting extracellular matrix degradation of alveolar macrophages

Protective Effect of Liriodendrin on IgG Immune Complex-Induced Acute Lung Injury Via Inhibiting SRC/STAT3/MAPK Signaling Pathway: a Network Pharmacology Research

CXCL10/IP-10 Neutralization Can Ameliorate Lipopolysaccharide-Induced Acute Respiratory Distress Syndrome in Rats

A Stromal Cell-Derived Factor 1α Analogue Improves Endothelial Cell Function in Lipopolysaccharide-Induced Acute Respiratory Distress Syndrome

MiR-199a-3p-regulated Alveolar Macrophage-Derived Secretory Autophagosomes Exacerbate Lipopolysaccharide-Induced Acute Respiratory Distress Syndrome.

Activation of SIRT1 Ameliorates LPS-induced Lung Injury in Mice Via Decreasing Endothelial Tight Junction Permeability

Soluble SIRP-Alpha Promotes Murine Acute Lung Injury Through Suppressing Macrophage Phagocytosis.

Schisantherin A Protects Lipopolysaccharide-Induced Acute Respiratory Distress Syndrome in Mice Through Inhibiting NF-κB and MAPKs Signaling Pathways

Impaired airway epithelial barrier integrity was mediated by PI3Kδ in a mouse model of lipopolysaccharide-induced acute lung injury

Mechanism Of Cxc Chemokine Ligand 5 (Cxcl5)/Cxc Chemokine Receptor 2 (Cxcr2) Bio-Axis In Mice With Acute Respiratory Distress Syndrome